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When susceptibility to diseases is caused by cis-effects of multiple alleles at adjacent poly-
morphic sites, it may be difﬁcult to assess with conﬁdence the genetic phase and identify
individuals carrying the risk haplotype. Experimental assessment of genetic phase is still
challengingandmostpopulationstudiesusestatisticalapproachestoinferhaplotypesgiven
the observed genotypes. While these statistical approaches are powerful and have been
proven very useful in large scale genetic population studies, they may be prone to errors
in studies with small sample size, especially in the presence of compound heterozygotes.
Here, we describe a simple and novel approach using the popular PCR–RFLP based strat-
egy to assess the genetic phase in compound heterozygotes.We apply this method to two
extensively studied SNPs in two clustered immune-related genes: The −308 (G>A) and
the +252 (A>G) SNPs of the tumor necrosis factor (TNF) alpha and the lymphotoxin alpha
(LTA) genes, respectively. Using this method, we successfully determined the genetic
phase of these two SNPs in known compound heterozygous individuals and in every sam-
ple tested.We show that the A allele ofTNF −308 is carried on the same chromosome as
the LTA 252(G) allele. +
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INTRODUCTION
SNPs are useful in mapping disease susceptibility genes. However,
theSNPsidentiﬁedfromtypicalgeneticmappingstudiesoftenare
not the causal SNPs but may tag the true causal mutation if they
are in linkage disequilibrium with each other (Ardlie et al., 2002;
Gabriel et al., 2002; Ke et al., 2004). To increase heterozygosity,
genetic information, and statistical power, haplotypes are usually
reconstructed from observed genotypes to identify the individu-
als carrying the risk haplotypes. Haplotypes are also valuable for
exploring cis-effects of speciﬁc combinations of intragenic poly-
morphisms,suchasthosevariationslocatedingenepromoters,or
polymorphisms in closely linked genes where there may be inter-
action that affects gene expression (Levenstien et al., 2006; Fan
et al.,2011).
Statisticalandcomputationalmethodscanprovidehighlyaccu-
rate estimates of haplotypes reconstructed from conventional
genotype data in most situations, but even the best method can
havealargeerrorrateofmorethan35%fordatasetswhereparental
genotypes are unknown (Stephens and Donnelly, 2003; Marchini
etal.,2006;Browning,2008;Liuetal.,2008).Severalexperimental
methodsforhaplotypeandgeneticphasedeterminationhavebeen
reported, including cloning (Burgtorf et al., 2003; Kitzman et al.,
2011), hybridization (Yan et al., 2000; Douglas et al., 2001; Boldt
and Petzl-Erler, 2002), polony technology (Mitra et al., 2003),
MALDI-TOF mass spectrometry (Tost et al., 2002), sequencing
(Levy et al., 2007), and chromosome micro-dissection (Ma et al.,
2010). However,these methods are labor-intensive and/or require
specialized and expensive equipment. PCR-based methods, such
as allele-speciﬁc PCR and isolation of single DNA molecules have
been used in the past to determine haplotypes and genetic phase
(Ruano et al., 1990; Michalatos-Beloin et al., 1996; Zhang et al.,
2006), but experimental optimization is needed and/or is labor-
intensive. All of the above methods may not be applicable in
settings where cost is a premium and specialized equipment is not
available or personnel have little or no training in labor-intensive
methodologies.
Wepresenthereasimpleapplicationof thepopularPCR–RFLP
basedstrategytodeterminethegeneticphaseattwoadjacentSNPs
in compound heterozygous individuals. Speciﬁcally, we looked
at rs909253 (A>G) at position +252 of the lymphotoxin alpha
(LTA) gene and about 3kb downstream, rs1800629 (G>A), at
position −308 of the tumor necrosis factor (TNF) alpha gene
in the major histocompatibility complex. Using this method, we
determinedthephaseof thesetwoSNPsinnineindividualsshown
in a previous study to be heterozygous both at the LTA +252 and
the TNF −308 positions (Aissani et al., 2009).
MATERIALS AND METHODS
DNA was extracted from peripheral blood mononuclear cells
(Qiagen, Valencia, CA, USA) obtained from nine subjects who
were double heterozygotes for the LTA +252 and TNF −308
SNPs (Aissani et al., 2009). Human subject approval was given
by the Institutional Review Board at UAB and informed consent
was obtained from all subjects. DNA quantitation was deter-
mined by a ﬂuorometric method using the Qubit™ﬂuorome-
ter (Invitrogen, Carlsbad, CA, USA). For the ﬁrst PCR, 50ng
of DNA from each subject were used to amplify the 3.4-kb
fragment separating the LTA and TNF SNPs. Due to the large
size of the fragment to be ampliﬁed and its high GC content
(75%), we used the Qiagen LongRange PCR kit. All primers
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were designed using Primer 3 (http://frodo.wi.mit.edu/primer3/).
A ﬁnal concentration of 0.4μM of primers L–T for-
ward (5 -GCTTCGTGCTTTGGACTACC-3 ) and reverse (5 -
GTCCTTTCCAGGGGAGAGAG-3 )w e r ea d d e dt oa2 5 - μl reac-
tion containing 2.5mM Mg++, 500μM of each dNTP, 1× Q-
solution, and two units of enzyme. DNA ampliﬁcation was per-
formed at an initial denaturation at 95˚C for 3min followed by
35 cycles of denaturation at 95˚C/30s,annealing at 62˚C/30s,and
extension at 68˚C for 3min. After product speciﬁcity was tested
and conﬁrmed by agarose gel electrophoresis, the products were
puriﬁed using the Qiagen PCR puriﬁcation kit. Approximately
5μlo f2 5μl puriﬁed product were digested with two and one-
half unitsof NcoIrestrictionendonucleaseenzyme(NEB,Ipswich,
MA,USA) in a total reaction of 25μl for 1h at 37˚C. The digested
and undigested samples were run in adjacent lanes along with a
1-kb size standard (Fermentas,Glen Burnie,MD,USA) on a 1.2%
agarose gel. The samples were run ﬁrst for 16h at 20V constant
overnightandthen40Vfor7hinordertoobtainsufﬁcientsepara-
tionof thefragmentsforremovalfromthegel.Thegelwasstained
with ethidium bromide for 30min, followed by destaining in 1×
TBE for 10min. Under low UV light, the shorter 3.2kb digested
NcoI fragment containing the G allele at LTA +252 was identiﬁed
and sliced from the gel.
The DNA fragment was eluted from the gel slice using
the QIAquick Gel Extraction Kit. For the second PCR, TNF
forward (5 -GCCCCTCCCAGTTCTAGTTC-3 ) and reverse (5 -
TTGGAAAGTTGGGGACACAC-3 ) primers were designed to
ﬂank the TNF −308 site. We generated a 248-bp PCR fragment
from 1μl of gel puriﬁed product in a 20-μl reaction contain-
ing 0.5μM each of primers and standard PCR reagents (200μM
dNTPs,1.5mMMg++,andoneunitof Amplitaq;AppliedBiosys-
tems, Foster City, CA, USA). After an initial denaturation at 95˚C
for 3min, 35 cycles of denaturation at 95˚C/30s, annealing at
56˚C/30s, and extension at 72˚C/30s were performed, followed
by a ﬁnal extension of 72˚C for 5min. The PCR product was puri-
ﬁedthroughsilicacolumns(Qiagen,Valencia,CA,USA)toremove
dNTPs and non-incorporated primers. To identify the allele at the
TNF −308 site, the nucleotide sequence of the puriﬁed 248bp
fragment was determined by Big Dye terminator cycle sequencing
on a 3730 Genomic Analyzer (Applied Biosystems, Forrest City,
CA, USA) using the TNF reverse primer.
RESULTS
Figure1showsthelocationsoftheLTA +252andTNF −308SNPs
in the initial 3.4kb PCR product and in the resulting 3.2kb NcoI
digested fragment when the“G”allele is present at the LTA +252
site. Since each of the nine samples was heterozygous for the LTA
+252 SNP (A>G), digestion of the PCR product with NcoIg e n -
erated DNA fragments of 3.4 and of 3.2kb of length carrying the
“A” and the “G” alleles, respectively (Figure 2). Because allele “G”
of LTA +252 can occur with either“A”or“G”allele of TNF −308,
genetic phase was determined by sequencing the 3  end of the 3.2-
kb NcoI fragment that encompasses the TNF −308 site. Figure 3
shows the DNA sequences surrounding the TNF −308 site in the
ninetestedsamples.Ascanbeseen,allninesamplescarrytheTNF
−308“A”allele (displayed as the“T”allele on the reverse strand).
Therefore,allninesubjectswhohadthe“G”alleleattheLTA +252
FIGURE 1 | Location of LTA +252 andTNF −308 SNPs in PCR product
and NcoI fragment.
FIGURE 2 | Gel separation of digested and undigested NcoI fragments.
Lane 1: 1kb size std.; Lane 2: NcoI digest of PCR from subject 1; Lane 3:
ﬁrst PCR product from subject 1.
site possess the“A”allele at the TNF −308 site. Since all nine indi-
viduals are known compound heterozygotes (Aissani et al.,2009),
Frontiers in Genetics | Genomic AssayTechnology January 2012 | Volume 2 | Article 108 | 2Perry et al. Genetic phase in compound heterozygotes
FIGURE 3 | Sample sequences ofTNF −308 SNP on NcoI digested fragment (3
 strand). “T” nucleotide on the 3
  strand represents theTNF −308 “A” allele
on 5
  strand.
thephaseontheotherchromosomemustbeLTA +252(A)–TNF
−308 (G).
DISCUSSION
For population studies where often hundreds or thousands of
individuals are sampled, phase determination can usually be sta-
tistically inferred, i.e., probabilistically. Family data can also assist
in determining phase. However, if only a few subjects are geno-
typed,determining phase usually must rely on laborious methods
suchaspuriﬁcationofsinglemoleculestoisolatethealleles.Allele-
speciﬁc PCR is relatively simple but is limited by the demand of
allele-speciﬁcoligoswhichmaynotalwaysbecompatiblewithefﬁ-
cient ampliﬁcation. The PCR–RFLP technique we present here is
a simple, cost–effective way to determine phase when compound
heterozygotes are present, especially in studies of small sample
size or when family data are not available. This method does not
requireexpensiveequipmentandcanbeperformedwiththebasic
tools found in most laboratories with only moderate technical
experience. There are a couple of factors that can affect or even
restrict the use of this technique. If one of the SNPs is not a
restriction site, allele-speciﬁc PCR could be utilized as an alter-
native. However, our method is more ﬂexible than allele-speciﬁc
PCR as any heterozygous site upstream of the SNP sites of interest
couldbeusedtogeneratefragmentswithdifferentelectrophoretic
mobilities, although sequencing across both SNPs on the shorter
fragmentwouldbenecessary.Here,therewasnoneedtosequence
through the LTA +252 site because the allele was determined by
RFLP. Size is an obvious limitation of the technique we present
here since a template of ∼40kb approaches the upper limit for
successfulampliﬁcation.Finally,someinitialoptimizationof PCR
and electrophoretic conditions, such as the presence of difﬁcult
sequences (e.g., GC content) and similarly sized cut and uncut
fragments,may be necessary.
We present here a simple, cost–effective method for determin-
ing genetic phase between SNPs in compound heterozygotes. We
were able to use this PCR–RFLP procedure to determine phase for
two SNPs that are 3kb apart in nine such individuals. Speciﬁcally,
using this procedure, we show that allele A of TNF −308 is in
complete disequilibrium with allele G of LTA +252. This proce-
dure would be very helpful for diseases or conditions where the
clinical manifestation and/or outcome are associated with haplo-
types.Exceptforsequencing,whichcanbeoutsourcedtorelatively
inexpensive sequencing services,this procedure can be performed
in most labs with only moderate technical experience and with no
expensive equipment or high up-front cost. This technique could
eventually be applied in clinical settings where disease susceptibil-
ityorvariabilityinexpressionisanurgentneed.Althoughthereare
certain situations that can limit the practical use of this approach,
the simple design,and relatively inexpensive cost makes it a viable
alternative to current methods.
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